Sign In
Pricing

300220 (Harmonized System 1992 for 6-digit)

2022
World Trade $89.2BRnk 32 / 4648
2022
Top Exporter | Top Importer $35.2B | $12.1BBelgium | Belgium
2022
Product Complexity 1.51Rnk 186 / 4653
2021 - 2022
Export Growth (CAGR) -22.6%Rnk 4369 / 4648
2022
Share of World Trade 0.38%Rnk 32 / 4648

About

Overview This page contains the latest trade data of Vaccines, human use. In 2022, Vaccines, human use were the world's 32nd most traded product, with a total trade of $89.2B. Between 2021 and 2022 the exports of Vaccines, human use decreased by -22.6%, from $115B to $89.2B. Trade in Vaccines, human use represent 0.38% of total world trade.

Vaccines, human use are a part of Vaccines, blood, antisera, toxins and cultures.

Exports In 2022 the top exporters of Vaccines, human use  were Belgium ($35.2B), Ireland ($12.1B), United States ($8.16B), Germany ($7.43B), and France ($5.56B).

Imports In 2022 the top importers of Vaccines, human use were Belgium ($12.1B), United States ($10.8B), Japan ($8.82B), Germany ($8.56B), and Spain ($4.08B).

Ranking Vaccines, human use ranks 186th in the Product Complexity Index (PCI).

Description A vaccine is a substance that creates immunity against a disease. It is typically administered by injection, but may be administered orally or by aerosol. Vaccines can protect against many infectious diseases including measles, mumps, tetanus, polio, rubella, and hepatitis A.

Latest Trends

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Vaccines, human use. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

Explore Latest Trends

* Trade values are converted to USD using each month's exchange rate. For December 2023 data, the exchange rate from December 30, 2023 is used.

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2022)Belgium$35.2B
Top Destination (2022)Belgium$12.1B

In 2022 Vaccines, human use were the world's 32nd most traded product (out of 4,648).

In 2022, the top exporters of Vaccines, human use were Belgium ($35.2B), Ireland ($12.1B), United States ($8.16B), Germany ($7.43B), and France ($5.56B).

In 2022, the top importers of Vaccines, human use were Belgium ($12.1B), United States ($10.8B), Japan ($8.82B), Germany ($8.56B), and Spain ($4.08B).

Explore Visualizations

Exporters of Vaccines, human use (2022)
[Click to Select a Country]

Importers of Vaccines, human use (2022)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (2021 -  2022)Ireland$5.59B
Top Destination Growth (2021 -  2022)Japan$3.3B

Between 2021 and 2022, the exports of Vaccines, human use grew the fastest in Ireland ($5.59B), Italy ($928M), South Korea ($412M), France ($282M), and Denmark ($207M).

Between 2021 and 2022, the fastest growing importers of Vaccines, human use were Japan ($3.3B), United States ($2.43B), China ($1.46B), Singapore ($478M), and Nigeria ($375M).

Explore Visualizations

Exporters of Vaccines, human use (2021 - 2022)

Importers of Vaccines, human use (2021 - 2022)

Market Concentration

Value

This chart shows the evolution of the market concentration of exports of Vaccines, human use.

In 2022, market concentration measured using Shannon Entropy, was 3.1. This means that most of the exports of Vaccines, human use are explained by 8 countries.

Explore Visualizations

Value of Exports in Vaccines, human use

Net Trade

TOP NET EXPORTER (2022)Belgium$23.1B
TOP NET IMPORTER (2022)Japan$8.73B

This map shows which countries export or import more of Vaccines, human use. Each country is colored based on the difference in exports and imports of Vaccines, human use during 2022.

In 2022, the countries that had a largest trade value in exports than in imports of Vaccines, human use were Belgium ($23.1B), Ireland ($11.7B), France ($2.95B), Switzerland ($2.14B), and Italy ($1.63B).

In 2022, the countries that had a largest trade value in imports than in exports of Vaccines, human use were Japan ($8.73B), United States ($2.66B), United Kingdom ($2.06B), Canada ($1.88B), and Australia ($1.85B).

Net Trade (2022)

Country Comparison

Flow
Measure
Ranking

This visualization shows the countries that have an important ratio of their trade related to Vaccines, human use.
It is possible to select the main countries that export or import Vaccines, human use in the world, or by continent, as well as select the measure of interest.

Top 10 Exporters Countries of Vaccines, human use by percentage of total exports

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2022)

Keep Exploring

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with
About the OECPrivacy PolicyTerms